Novartis AG
F:NOT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Novartis AG
F:NOT
|
CH |
|
N
|
Norfolk Southern Corp
XETRA:NFS
|
US |
|
MTR Corp Ltd
F:MRI
|
HK |
|
K
|
Kuehne und Nagel International AG
XHAM:KNIA
|
CH |
|
S
|
Sif Holding NV
F:276
|
NL |
|
Carrefour SA
XETRA:CAR
|
FR |
|
A
|
American Superconductor Corp
F:AMS1
|
US |
Wall St Price Targets
NOT Price Targets Summary
Novartis AG
According to Wall Street analysts, the average 1-year price target for NOT is 135.34 EUR with a low forecast of 99.96 EUR and a high forecast of 159.88 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NOT's stock price target?
Price Target
135.34
EUR
According to Wall Street analysts, the average 1-year price target for NOT is 135.34 EUR with a low forecast of 99.96 EUR and a high forecast of 159.88 EUR.
What is the Revenue forecast for Novartis AG?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Novartis AG?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 8 years is 6%.
What is the Net Income forecast for Novartis AG?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 8 years is 7%.
